Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study - Concepedia

Concepedia

Publication | Open Access

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study

DOI Full Paper Access

16

Citations

36

References

2015

Year

Bernhard Manger, Falk Hiepe, Peter Wimmer, Eva‐Maria Paulus, Matthias Schneider, Margitta Worm, Andreas Schwarting

Clinical and Experimental Gastroenterology

Abstract

Patients switched to EC-MPS experienced less gastrointestinal symptom burden and showed improvement in HRQoL.

References

	Year	Citations

Page 1